05/14/2025 | Press release | Distributed by Public on 05/14/2025 14:32
OPERATING AND FINANCIAL REVIEW AND PROSPECTS |
|
A. |
Operating Results
|
|
• |
OIC subscribed for and purchased from the Company Class A redeemable preferred shares with a 12% fixed accumulating distribution (the "Preferred Shares") and warrants ("SEF Warrants") for aggregate gross proceeds of US$35 million (equivalent to A$54.7 million) less transaction costs.
|
|
• |
The Class A preference shares are recognized as a financial liability at amortized cost as they must be redeemed by November 2028. The Company may elect to redeem Class A preferred shares on issue at an earlier date at its discretion subject to a return to the holder the greater of (i) a 1.75x Multiple on Invested Capital ("MOIC") return on face value, or (ii) a 12% IRR.
|
|
• |
The SEF warrants carry a US$0.01 strike price and entitle OIC to up to a maximum 19.99% of the fully diluted Company shares on issue (subject to, in tranches, certain milestones including the further issuance of Class A shares below). The warrant may be exercised, in whole or in part, at the discretion of the holder. The warrant terms initially included a 'cashless' exercise feature which was subsequently removed in June 2024. The warrants were treated as derivative liabilities at fair value through profit and loss between issuance in November 2023 and June 2024, resulting in a gain of A$5.8 million for the 2024 financial year. In June 2024 the warrants were reclassified to equity as the Company considered them to now meet the fixed for fixed criteria in IAS32 upon OIC's undertaking on the cashless exercise feature.
|
|
• |
The proceeds were allocated on a fair value basis, firstly to the SEF warrant derivative liability and then the residual to the Class A preferred share obligation. Transaction costs were allocated on a relative fair value basis.
|
|
• |
OIC also provided commitments in November 2023 to purchase further tranches of preferred shares subject to achievement of certain milestones for which US$35 million was placed in escrow. The Company has not recognized any financial liability or allocation of proceeds in November 2023 or during the 2024 financial year for these preferred shares as the associated escrow deposit was not considered to be within the control of the Company. These commitments and escrow arrangements were subsequently modified in June 2024 on issuance of loan notes to OIC.
|
|
• |
Of the SEF warrants of up to 19.99% of the fully diluted Company shares on issue, 12.49% vested on completion of the initial US$35 million funding, a further 5% would vest on release of the US$35 million held in escrow (such release subject to certain conditions and milestones), and the final 2.5% would vest on release of the final US$40 million funding (such release subject to certain conditions and milestones including OIC investment committee approval).
|
|
• |
The proceeds received from the issuance of Class A Preferred Shares under the OIC financing must generally be used consistent with a budget agreed between the Company and OIC.
|
|
• |
US$5 million advanced in the form of Class B Preferred Shares in April 2024, and US$30 million advanced in the form of loan notes (Series 2024-A notes) between May 2024 and October 2024 (of which US$10 million was advanced during the financial year ending June 30, 2024);
|
|
• |
In relation to the Class B Preferred Shares: mandatory redemption on November 3, 2028 aligned with the Class A Preferred Shares, with a 12% fixed accumulating dividend, and the Company may elect to redeem outstanding Class B Preferred Shares at an earlier date at its discretion subject to returning to the holder the greater of (i) a 1.75x MOIC return on face value, or (ii) a 12% IRR.
|
|
• |
In relation to the Series 2024-A Notes, maturity date of May 2027 concurrent with maturity of the New Debt Program / USD term loan;
|
|
• |
In relation to the Series 2024-A Notes, 12% interest comprising an 8.5% coupon rate payable monthly and a further 3.5% monthly payment in kind (which is capitalized progressively into the amount outstanding);
|
|
• |
In relation to the Series 2024-A Notes, progressive monthly repayments of principal commencing June 2026 - concurrent with the modified 2023 USD term loan;
|
|
• |
An exit premium payable on the Series 2024-A Notes of 2.0x invested capital plus a further $10 million, such exit premium being payable upon the earlier of a refinancing of the Series 2024-A notes, sale of the Company or maturity in May 2027, inclusive of any principal and interest payments to date. The repayment of the exit premium in full will be reduced or delayed in certain limited circumstances;
|
|
• |
The exit premium on the Class B Preferred Shares is reduced by an amount equal to the amount of cash dividends and redemption payments that have been paid to the holder(s) of Class B Preferred Shares; equally the amounts required to redeem the Class B Preferred Shares are reduced on account of payments made towards the exit premium, and where the amount required to redeem the Class B Preferred Shares is reduced to zero, the holder(s) of the Class B Preferred Shares will surrender those shares for no additional consideration;
|
|
• |
The Company obtained a modification of the 2023 USD term loan such that it would rank equally to the Series 2024-A notes issued; and
|
|
• |
Further, US$0.01 SEF warrants to purchase a number of ordinary shares equivalent to 25.35% of ordinary shares issued calculated on a fully diluted basis (as defined in the OIC warrant) at the time of exercise, the terms of which are equivalent to the November 2023 SEF warrants.
|
|
• |
Successful launches of production of new programs. Three programs have recently entered production and a further four awarded programs are currently in development or launch phase. These programs are in the performance or premium/luxury/SUV and pick-up segments and include both internal combustion engine and EV drivetrains. We expect these programs currently in development or launch phase to commence production during CY25;
|
|
• |
Award of new customer programs. The Company is in discussions with customers and potential new customers about new wheel programs and expects that it will win new customer program awards which, together with existing awarded programs (both those currently in production and yet to enter production) would aim to fill the capacity at the existing Australian manufacturing facility (such capacity is being added over time in line with expected demand);
|
|
• |
Following completion of the initial phase of the Mega-line, further expansion of the production capacity of the Mega-line and other areas of the plant through both efficiency gains, driving the industrialization of production processes, and additional associated investments across the facility, to support expected future production requirements for awarded programs;
|
|
• |
Improvement in gross margin, with further efficiencies expected as further programs come online and volume ramps; and
|
|
• |
Leveraging the benefits of expected increased volumes in the Australian facility during the second half of the calendar year and realizing the benefits of the investment in automation and capacity increases, reducing material costs through improved prices from certain suppliers as a result of volume increases, substituting certain materials with lower cost materials, sourcing certain materials from lower cost providers, shifting certain supply arrangements from spot purchases to long term contracts, consolidating consumables suppliers, and implementing production processes and designs which utilize less material and production consumables. Overheads are also being managed closely to align requirements with the Company's program development lifecycles.
|
|
• |
Meeting the conditions for the release of the remaining US$5 million of the US$25 million of OIC funding agreed pursuant to the December 2024 Amendments, the release from the payment reserve fund of the remaining US$0.4 million of the US$2 million agreed to be released pursuant to the December 2024 Amendments, and the waiver of US$3 million cash interest by the Existing Lenders for the Cash Interest Suspension Period, and the waiver by the OIC Investors of an approximately equivalent amount of cash interest on the Series 2024-A Notes and the Series 2025-A Notes, on the same terms, for the same period, pursuant to the December 2024 Amendments;
|
|
• |
Securing agreement for ongoing deferral of previously agreed transaction costs deferrals from the capital reorganization (as per Note 3.6.1) amounting to a total of US$15.0 million (A$22.5 million). Under an agreement the Group had reached with these creditors to delay payment, US$5 million (A$7.6 million) was payable in November 2024, with the remainder to be paid from the proceeds of certain fundraising transactions or on a straight line basis over 5 years (depending on the option selected by the supplier). The US$5 million (A$7.6 million) payment was not made in November 2024 and a further US$10.0 million (A$15.0 million) is now payable or payable during the next 12 months from signing date, unless the relevant suppliers agree to or accept further deferral of the transaction costs for at least twelve months from signing date and until sufficient cashflow can be generated from operations or alternative sources of funding are obtained to pay down these debts;
|
|
• |
Securing agreement from key customers for ongoing bailment payments for shipped wheels to provide working capital relief;
|
|
• |
Pursuing certain claims against certain customers, including claim for payment for wheels shipped but not yet utilized in production by a customer, potential claims in relation to programs in which ordered volumes have been below the volumes which the Company was required to build and reserve capacity for under its customer contracts, and a claim in relation to cancellation of a wheel program;
|
|
• |
Securing continued support from suppliers in the form of deferred payment terms; and
|
|
• |
Compliance with the terms of the MMI grant and receipt of the remaining milestone-based A$0.5 million funding amount payable under the MMI grant.
|
|
• |
Potential repurposing of the remaining US$15 million of the up to US$110 million contemplated under the original OIC Financing. The final US$40 million of the up to US$110 million OIC Financing was intended to be for the purpose of funding towards a new manufacturing facility. Assuming OIC releases the final US$5 million tranche of the US$25 million of OIC funding agreed pursuant to the December 2024 Amendments, a further US$15 million of the up to US$110 million contemplated under the original OIC Financing will remain. If the Company did require near term assistance after exhausting all other reasonable sources of liquidity, OIC may consider repurposing these funds to support the Company's pathway to profitability in Australia; and
|
|
• |
Potential access to capital through the issuance of other debt or equity securities via public or private placement or utilization of the Committed Equity Facility through the equity purchase agreement with Yorkville Advisors.
|
|
B. |
Liquidity and Capital Resources
|
Cashflow
|
2024
A $m
|
|
2023
A $m
|
2022
A $m
|
Change
2024 -
2023
A
$m
|
||||||
Net cash used in operating activities
|
(76.8
|
) |
(52.5
|
) |
(46.0
|
) |
(24.3
|
) |
|||
Payments for property, plant & equipment
|
(19.6
|
) |
(13.1
|
) |
(15.6
|
) |
(6.5
|
) |
|||
Payments for intangible assets
|
(5.4)
|
|
(4.9)
|
(6.0
|
) |
(0.6
|
) |
||||
Net cash used in investing activities
|
(25.1
|
) |
(18.0
|
) |
(21.6
|
) |
(7.1
|
) |
|||
Net cash provided by financing activities
|
85.1
|
|
66.5
|
3.3
|
18.6
|
||||||
Net (decrease)/increase in cash and cash equivalents held
|
(16.8
|
) |
(4.0
|
) |
(64.3
|
) |
(12.8
|
) |
|
• |
meeting the conditions for the release of the remaining US$5 million (A$7.6 million) of the US$25 million (A$37.9 million) of OIC funding agreed pursuant to the December 2024 Amendments, the release from the payment reserve fund of the remaining US$0.4 million (A$0.7 million) of the US$2 million (A$3.0 million) agreed to be released pursuant to the December 2024 Amendments, and the waiver of US$3 million (A$4.5 million) cash interest by the Existing Lenders for the Cash Interest Suspension Period, and the waiver by the OIC Investors of an approximately equivalent amount of cash interest on the Series 2024-A Notes and the Series 2025-A Notes, on the same terms, for the same period, pursuant to the December 2024 Amendments;
|
|
• |
potential repurposing of the remaining US$15 million (A$22.7 million) of the up to US$110 million (A$166.7 million) contemplated under the original OIC Financing. The final US$40 million (A$60.6 million) of the up to US$110 million (A$166.7 million) OIC Financing was intended to be for the purpose of funding towards a new manufacturing facility. Assuming OIC releases the final US$5 million (A$7.6 million) tranche of the US$25 million (A$37.9 million) of OIC funding agreed pursuant to the December 2024 Amendments, a further US$15 million (A$22.7 million) of the up to US$110 million (A$166.7 million) contemplated under the original OIC Financing will remain. If the Company did require near term assistance after exhausting all other reasonable sources of liquidity, OIC may consider repurposing these funds to support the Company's existing operations in Australia;
|
|
• |
its unrestricted cash balance of A$1.5 million at April 30, 2025; and
|
|
• |
potential access to capital through the potential issuance of other debt or equity securities via public or private placement and under the Committed Equity Facility ("CEF").
|
|
• |
Achieving the Company's operating plan (for a summary of the key focus areas for 2025, refer to "Item 5. Operating and Financial Review and Prospects-A. Operating Results-Key Factors Affecting Operating Results in Future Periods-2025 Business Outlook");
|
|
• |
Meeting the conditions for the release of the remaining US$5 million (A$7.6 million) of the US$25 million (A$37.9 million) of OIC funding agreed pursuant to the December 2024 Amendments, the release from the payment reserve fund of the remaining US$0.4 million (A$0.7 million) of the US$2 million (A$3.0 million) agreed to be released pursuant to the December 2024 Amendments, and the waiver of US$3 million (A$4.5 million) cash interest by the Existing Lenders for the Cash Interest Suspension Period, and the waiver by the OIC Investors of an approximately equivalent amount of cash interest on the Series 2024-A Notes and the Series 2025-A Notes, on the same terms, for the same period, pursuant to the December 2024 Amendments;
|
|
• |
Achieving forecast production levels, sales mix and pricing;
|
|
• |
Reducing unit costs, reducing fixed overheads and limiting non-contracted capital expenditures in accordance with cost reduction initiatives;
|
|
• |
Securing agreement for ongoing deferral of previously agreed transaction costs deferrals from the capital reorganization (as per Note 3.6.1) amounting to a total of US$15.0 million (A$22.5 million). Under an agreement the Group had reached with these creditors to delay payment, US$5 million (A$7.6 million) was payable in November 2024, with the remainder to be paid from the proceeds of certain fundraising transactions or on a straight line basis over 5 years (depending on the option selected by the supplier). The US$5 million (A$7.6 million) payment was not made in November 2024 and a further US$10.0 million (A$15.0 million) is now payable or payable during the next 12 months from the date of the filing of this Annual Report, unless the relevant suppliers agree to or accept further deferral of the transaction costs for at least twelve months from signing date and until sufficient cashflow can be generated from operations or alternative sources of funding are obtained to pay down these debts;
|
|
• | ongoing support from suppliers and customers in the form of favorable payment terms and bailment payments; |
|
• |
Successful outcome of claims which the Group has made or plans to make against customers primarily associated with ordered volumes that are below the volumes which the Group was required to build and reserve capacity for under its customer contracts, and cancellation of a wheel program; and
|
|
• | Raising capital to fund operations through the issuance of debt or equity securities via public or private placement (including through the CEF). |
as of
June 30, 2024
AUD $m
|
as of
June 30, 2023
AUD $m
|
|||||||
Right-of-use assets
|
||||||||
Property
|
-
|
7.4
|
||||||
Lease liabilities
|
||||||||
Current
|
0.7
|
0.6
|
||||||
Non-current
|
7.1
|
7.4
|
||||||
7.8
|
8.0
|
Interest rate %
|
Maturity
|
as of
June 30, 2024
AUD $m
|
as of
June 30, 2023
AUD $m
|
|||||||||||
Current borrowings
|
||||||||||||||
Unsecured
|
||||||||||||||
Term loan with customer
|
10.00
|
%
|
June 2024
|
-
|
4.5
|
|||||||||
Supplier finance arrangement
|
6.00%
+ RBA cash rate
|
June 2025
|
14.0
|
9.3
|
||||||||||
Lease liabilities
|
|
0.7 |
0.6
|
|||||||||||
14.7
|
14.5
|
|||||||||||||
Non-current borrowings
|
||||||||||||||
Secured
|
||||||||||||||
OIC Class A preferred shares
|
12.00
|
%
|
November 2028
|
46.4
|
-
|
|||||||||
USD Term loan
|
12.00
|
%
|
May 2027
|
78.5
|
70.8
|
|||||||||
OIC Series 2024-A notes
|
12.00
|
%
|
May 2027
|
10.9
|
-
|
|||||||||
OIC Class B preferred shares (USD)
|
12.00 |
% |
November 2028 |
5.1 |
- | |||||||||
Derivative liabilities - Warrants
|
|
|
0.5
|
- | ||||||||||
Lease liabilities
|
|
7.1 |
7.4 | |||||||||||
148.4
|
78.2
|
|
• |
Interest only is payable until June 2026, and from June 2026 interest will continue to be payable each month together with monthly principal repayments of USD$2 million until maturity in May 2027 with the remaining balance of the principal being paid as a balloon payment at maturity;
|
|
• |
Interest will be payable at 12% per annum (8.5% pa coupon plus an additional 3.5% accumulating paid-in-kind interest); and
|
|
• |
3% amendment fee (US$1.8 million) payable at maturity.
|
|
• |
US$5 million advanced in the form of Class B Preferred Shares in April 2024, and US$30 million advanced in the form of loan notes (Series 2024-A notes) between May 2024 and October 2024 (of which US$10 million was advanced during the financial year ending June 30, 2024);
|
|
• |
In relation to the Class B Preferred Shares: mandatory redemption on November 3, 2028 aligned with the Class A Preferred Shares, with a 12% fixed accumulating dividend, and the Company may elect to redeem outstanding Class B Preferred Shares at an earlier date at its discretion subject to returning to the holder the greater of (i) a 1.75x MOIC return on face value, or (ii) a 12% IRR.
|
|
• |
In relation to the Series 2024-A Notes, maturity date of May 2027 concurrent with maturity of the USD term loan;
|
|
• |
In relation to the Series 2024-A Notes, 12% interest comprising an 8.5% coupon rate payable monthly and a further 3.5% monthly payment in kind (which is capitalized progressively into the amount outstanding);
|
|
• |
In relation to the Series 2024-A Notes, progressive monthly repayments of principal commencing June 2026 - concurrent with the modified 2023 USD term loan;
|
|
• |
An exit premium payable on the Series 2024-A Notes of 2.0x invested capital plus a further $10 million, such exit premium being payable upon the earlier of a refinancing of the Series 2024-A notes, sale of the Company or maturity in May 2027, inclusive of any principal and interest payments to date. The repayment of the exit premium in full will be reduced or delayed in certain limited circumstances;
|
|
• |
The exit premium on the Class B Preferred Shares is reduced by an amount equal to the amount of cash dividends and redemption payments that have been paid to the holder(s) of Class B Preferred Shares; equally the amounts required to redeem the Class B Preferred Shares are reduced on account of payments made towards the exit premium, and where the amount required to redeem the Class B Preferred Shares is reduced to zero, the holder(s) of the Class B Preferred Shares will surrender those shares for no additional consideration;
|
|
• |
The Company obtained a modification of the 2023 USD term loan such that it would rank equally to the Series 2024-A notes issued; and
|
|
• |
Further, US$0.01 SEF warrants to purchase a number of ordinary shares equivalent to 25.35% of ordinary shares issued calculated on a fully diluted basis (as defined in the OIC warrant) at the time of exercise, the terms of which are equivalent to the November 2023 SEF warrants.
|
|
C. |
Research and development, patents and licenses, etc.
|
|
D. |
Trend Information
|
|
E. |
Critical Accounting Policies and Estimates
|
F.
|
SUPPLEMENTAL NON-IFRS MEASURES AND RECONCILIATIONS
|
2024
AUD $m
|
2023
AUD $m
|
2022
AUD $m
|
||||||||||
Net loss for the year
|
(221.1
|
)
|
(79.2
|
)
|
(47.8
|
)
|
||||||
Income tax expense
|
-
|
-
|
-
|
|||||||||
Depreciation & Amortization
|
13.2
|
10.5
|
9.0
|
|||||||||
Effective interest on third party borrowings
|
16.0
|
1.4
|
-
|
|||||||||
Cash Interest on third party borrowings
|
9.2
|
2.7
|
0.6
|
|||||||||
Interest on lease liabilities
|
0.3
|
0.3
|
0.3
|
|||||||||
Interest other
|
0.6
|
0.6
|
0.3
|
|||||||||
Interest income
|
|
|
(0.2
|
) |
|
|
(0.1 |
) |
|
|
(0.1
|
) |
Earnings before Interest, Tax, Depreciation & Amortization (EBITDA)
|
|
|
(182.0 |
) |
|
|
(63.8
|
) |
|
|
(37.8
|
) |
Capital raising transaction costs
|
|
|
31.6 |
|
|
|
24.7 |
|
|
|
- |
|
Share based payment expenses
|
|
|
(0.2
|
) |
|
|
3.1 |
|
|
|
3.2 |
|
Impairment of assets
|
|
|
102.6 |
|
|
|
- |
|
|
|
- |
|
Loss on Modification
|
|
|
0.9 |
|
|
|
- |
|
|
|
- |
|
Loss on extinguishment
|
2.1
|
-
|
-
|
|||||||||
Supplier Financing costs
|
1.0
|
0.4
|
0.2
|
|||||||||
Realized foreign exchange loss
|
0.1
|
-
|
- | |||||||||
Gain on remeasurement of warrant liabilities
|
(6.7
|
)
|
-
|
- | ||||||||
Unrealized foreign exchange gain
|
(2.1
|
)
|
-
|
- | ||||||||
Adjusted EBITDA
|
(52.7 |
) |
(35.6
|
)
|
(34.3
|
)
|
as of
June 30, 2024
AUD $m
|
as of
June 30, 2023
AUD $m
|
as of June 30, 2022
AUD $m
|
||||||||||
Borrowings and other financial liabilities
|
||||||||||||
Current Borrowings and Lease Liabilities
|
14.7
|
14.5
|
19.3
|
|||||||||
Non-current Borrowings, Lease and Derivative Liabilities
|
148.4
|
78.2
|
11.8
|
|||||||||
Total Borrowings and other financial liabilities
|
163.1
|
92.7
|
31.1
|
|||||||||
Less: Cash and cash equivalents
|
(3.7
|
)
|
(19.6
|
)
|
(22.7
|
)
|
||||||
Less: Restricted trust fund
|
(7.7
|
)
|
(14.7
|
)
|
-
|
|||||||
Adjusted Net Debt
|
151.7
|
58.4
|
8.4
|